A detailed history of Morgan Stanley transactions in Novartis Ag stock. As of the latest transaction made, Morgan Stanley holds 7,258,381 shares of NVS stock, worth $749 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,258,381
Previous 7,092,253 2.34%
Holding current value
$749 Million
Previous $716 Million 1.96%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $15.8 Million - $18 Million
166,128 Added 2.34%
7,258,381 $702 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $10.6 Million - $11.6 Million
114,420 Added 1.64%
7,092,253 $716 Million
Q3 2023

Nov 15, 2023

SELL
$94.73 - $105.13 $27.2 Million - $30.2 Million
-287,598 Reduced 3.96%
6,977,833 $711 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $60.2 Million - $68.3 Million
650,965 Added 9.84%
7,265,431 $733 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $10.1 Million - $11.7 Million
126,270 Added 1.95%
6,614,466 $609 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $28.5 Million - $34.9 Million
377,693 Added 6.18%
6,488,196 $589 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $21.5 Million - $25.2 Million
-288,283 Reduced 4.51%
6,110,503 $464 Million
Q2 2022

Oct 27, 2022

BUY
$80.52 - $93.75 $252 Million - $294 Million
3,134,810 Added 96.04%
6,398,786 $541 Million
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $252 Million - $294 Million
3,134,810 Added 96.04%
6,398,786 $541 Million
Q1 2022

Oct 27, 2022

SELL
$80.11 - $90.62 $251 Million - $284 Million
-3,134,810 Reduced 48.99%
3,263,976 $286 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $17.6 Million - $19.9 Million
-219,673 Reduced 6.31%
3,263,976 $286 Million
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $21.3 Million - $23.6 Million
267,670 Added 8.32%
3,483,649 $305 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $263 Million - $306 Million
3,215,979 New
3,215,979 $263 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.